Anti-PD1 Drugs- Are The Reimbursed Indications Of The Marketing Authorization Respected?
May 1, 2018, 00:00
10.1016/j.jval.2018.04.254
https://www.valueinhealthjournal.com/article/S1098-3015(18)30554-0/fulltext
Title :
Anti-PD1 Drugs- Are The Reimbursed Indications Of The Marketing Authorization Respected?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30554-0&doi=10.1016/j.jval.2018.04.254
First page :
Section Title :
Open access? :
No
Section Order :
1125